Latest filings (excl ownership)
D/A
$1.4B in investment fund, sold $1.4B, 44 investors
30 Oct 19
D/A
Indefinite amount in investment fund, sold $1.3B, 38 investors
12 Aug 19
D/A
Indefinite amount in investment fund, sold $1.28B, 36 investors
3 Jun 19
D/A
Indefinite amount in investment fund, sold $863.98M, 29 investors
23 Jan 19
D/A
Indefinite amount in investment fund, sold $863.98M, 29 investors
6 Dec 18
D
Indefinite amount in investment fund
16 Aug 18
Latest ownership filings
4
IO Biotech, Inc.
10 Aug 23
4
Sierra Oncology, Inc.
1 Jul 22
4
Tarsus Pharmaceuticals, Inc.
5 May 22
4
Tarsus Pharmaceuticals, Inc.
4 May 22
4
Sierra Oncology, Inc.
31 Jan 22
4
Sierra Oncology, Inc.
28 Jan 22
4
IO Biotech, Inc.
12 Nov 21
3
IO Biotech, Inc.
4 Nov 21
4
Tarsus Pharmaceuticals, Inc.
25 Jun 21
4
Tarsus Pharmaceuticals, Inc.
25 Jun 21
4
Tarsus Pharmaceuticals, Inc.
16 Apr 21
4
Instil Bio, Inc.
25 Mar 21
3/A
Instil Bio, Inc.
22 Mar 21
3
Instil Bio, Inc.
18 Mar 21
4
Tarsus Pharmaceuticals, Inc.
20 Oct 20
3
Tarsus Pharmaceuticals, Inc.
15 Oct 20
4
ALX ONCOLOGY HOLDINGS INC
21 Jul 20
3
ALX ONCOLOGY HOLDINGS INC
16 Jul 20
4
Sierra Oncology, Inc.
31 Jan 20
3
Sierra Oncology, Inc.
2 Dec 19